Home/ Stocks/ SERA

Sera Prognostics, Inc. Class A Common Stock

SERA XNAS

$2.07 +0.07 (+3.50%) ▲ 15-min delayed

Open

$2.00

High

$2.20

Low

$1.85

Volume

61.4K

Market Cap

$78.32M

About Sera Prognostics, Inc. Class A Common Stock

Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Sector: SERVICES-MEDICAL LABORATORIES Employees: 72 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$14.0K	$-8,399,000	$-0.17
FY 2025	$81.0K	$-31,928,000	$-0.67
Q3 2025	$16.0K	$-7,814,000	$-0.16
Q2 2025	$17.0K	$-8,046,000	$-0.16

Related Market News

No specific coverage for SERA yet. Check out our latest market news or earnings calendar.

Get SERA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Sera Prognostics, Inc. Class A Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.